Becton Dickinson (BDX) Non-Current Assets (2009 - 2026)
Becton Dickinson's (BDX) quarterly Non-Current Assets came in at $42.6 billion in Q2 2026, down 7.22% year-over-year from $45.9 billion in Q2 2025, and down 0.53% quarter-over-quarter from $42.8 billion in Q1 2026.
Analysis
Becton Dickinson (BDX) Non-Current Assets (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Non-Current Assets for 18 consecutive years, with $42.6 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 7.22% year-over-year to $42.6 billion in Q2 2026; TTM through Jun 2026 was $177.1 billion, a 4.01% decrease from a year earlier, with the FY2025 full-year figure at $46.1 billion, down 1.6% from the prior year.
- Non-Current Assets was $42.6 billion for Q2 2026 at Becton Dickinson, down from $42.8 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $46.8 billion in Q3 2024 and troughed at $42.6 billion in Q2 2026.
- A 5-year average of $44.7 billion and a median of $44.7 billion in 2022 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets rose 6.15% in 2024 and dropped 7.22% in 2026, its largest moves.
- Over 5 years, Non-Current Assets stood at $45.0 billion in 2022, then dropped by 1.86% to $44.1 billion in 2023, then grew by 4.28% to $46.0 billion in 2024, then fell by 0.77% to $45.7 billion in 2025, then fell by 6.7% to $42.6 billion in 2026.
- The last three Non-Current Assets figures came in at $42.6 billion (Q2 2026), $42.8 billion (Q1 2026), and $45.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 42.59 Bn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 27.61 Bn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 2.27 Bn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 12.80 Bn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | - |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 88.31 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | 20.17 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 75.77 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 183,321.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | 1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.59 Bn |
| Mar 31, 2026 | 42.82 Bn |
| Dec 31, 2025 | 45.65 Bn |
| Sep 30, 2025 | 46.07 Bn |
| Jun 30, 2025 | 45.91 Bn |
| Mar 31, 2025 | 45.80 Bn |
| Dec 31, 2024 | 46.01 Bn |
| Sep 30, 2024 | 46.82 Bn |
| Jun 30, 2024 | 43.38 Bn |
| Mar 31, 2024 | 43.82 Bn |
| Dec 31, 2023 | 44.12 Bn |
| Sep 30, 2023 | 44.10 Bn |
| Jun 30, 2023 | 44.43 Bn |
| Mar 31, 2023 | 44.81 Bn |
| Dec 31, 2022 | 44.95 Bn |
| Sep 30, 2022 | 44.79 Bn |
| Jun 30, 2022 | 43.65 Bn |
| Mar 31, 2022 | 44.63 Bn |
| Dec 31, 2021 | 45.06 Bn |
| Sep 30, 2021 | 45.03 Bn |